Liver transplantation for malignancy: Current treatment strategies and future perspectives

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 18

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 14, 2014; 20(18): 5331-5344
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5331

Table 1 Indications and contraindications for liver transplantation in malignancy

Standard indications

HCC in cirrhosis within Milan criteria

FLC

Hepatoblastoma (pediatric patients)

Epithelioid hemangioendothelioma

Investigational indications

HCC in cirrhosis exceeding Milan criteria

HCC without cirrhosis

CCA

Neuroendocrine liver metastases

Contraindications

HCC with extrahepatic disease or macro-invasion into portal vein

Hepatoblastoma with uncontrolled extrahepatic disease

Malignancies other than the indications mentioned

Cancer Survivors with complete remission < 2-5 yr[153]

HCC: Hepatocellular carcinoma; FLC: Fibrolamellar carcinoma; CCA: Cholangiocellular adenocarcinoma.

Citation: Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M. Liver transplantation for malignancy: Current treatment strategies and future perspectives. World J Gastroenterol 2014; 20(18): 5331-5344
URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5331.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5331

Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M. Liver transplantation for malignancy: Current treatment strategies and future perspectives. World J Gastroenterol 2014; 20(18): 5331-5344 [PMID: 24833863 DOI: 10.3748/wjg.v20.i18.5331]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.